We present a case of a 61-year-old woman with an atypical non-arteritic anterior ischemic optic neuropathy (NA-AION) as a unique manifestation of COVID-19. Furthermore, the patient worsened after Pfizer-BioNTech COVID-19 vaccine administration. Our findings suggest that NA-AION could result from microangiopathic/thrombotic events that may occur during SARS-CoV-2 infection and/or vaccination against COVID-19. This report sheds light on possible ophthalmologic complications of COVID-19.
Romozzi, M., Amorelli, G. M., Savastano, M. C., Fedele, A. L., Amorelli, F., Rizzo, S., Lucchini, M., Mirabella, M., Nociti, V., COVID-19 presenting as a non-arteritic anterior ischemic optic neuropathy, <<EUROPEAN JOURNAL OF OPHTHALMOLOGY>>, 2023; 2023 (January): 11206721221149762-11206721221149762. [doi:10.1177/11206721221149762] [https://hdl.handle.net/10807/247414]
COVID-19 presenting as a non-arteritic anterior ischemic optic neuropathy
Romozzi, Marina;Amorelli, Giulia Maria;Savastano, Maria Cristina;Fedele, Anna Laura;Rizzo, Stanislao;Lucchini, Matteo;Mirabella, Massimiliano;Nociti, Viviana
2023
Abstract
We present a case of a 61-year-old woman with an atypical non-arteritic anterior ischemic optic neuropathy (NA-AION) as a unique manifestation of COVID-19. Furthermore, the patient worsened after Pfizer-BioNTech COVID-19 vaccine administration. Our findings suggest that NA-AION could result from microangiopathic/thrombotic events that may occur during SARS-CoV-2 infection and/or vaccination against COVID-19. This report sheds light on possible ophthalmologic complications of COVID-19.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
